Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
Clinical trial NCT00000794 · COMPLETED
Trial details
- NCT number
- NCT00000794
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.